The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Metabolic Dysfunction-Associated Fatty Liver Disease and Incident Cardiovascular Disease Risk: A Nationwide Cohort Study
Open accessAbstract
BACKGROUND & AIMS An international expert panel proposed a new definition for metabolic dysfunction-associated fatty liver disease (MAFLD) as a name change from nonalcoholic fatty liver disease (NAFLD). The clinical impact of this change on the assessment of cardiovascular disease (CVD) risk is yet unknown. We evaluated the prevalence of fatty liver disease (FLD) and the associated CVD risk using each of these definitions. METHODS From a nationwide health screening database, we included 9,584,399 participants (48.5% male) aged 40-64 years between 2009 and 2010. Participants were categorized by presence of NAFLD and MAFLD, separately, and by the combination of the two definitions-Neither-FLD, NAFLD-only, MAFLD-only, or Both-FLD. The primary outcome was a composite CVD event, including myocardial infarction, ischemic stroke, heart failure, or CVD-related death. RESULTS The prevalence of NAFLD and MAFLD was 28.0% and 37.3%, respectively. After excluding those with prior CVD, 8,962,813 participants were followed for a median of 10.1 years. NAFLD and MAFLD were each associated with significantly higher risk for CVD events. When the Neither-FLD group was the reference, multivariable-adjusted hazard ratios (95% confidence interval) for CVD events were 1.09 (1.03-1.15) in the NAFLD-only group, 1.43 (1.41-1.45) in the MAFLD-only group, and 1.56 (1.54-1.58) in the Both-FLD group. CONCLUSIONS A considerable proportion of middle-aged Korean adults have MAFLD without satisfying the former definition of NAFLD. The change from NAFLD to MAFLD criteria may identify a greater number of individuals with metabolically complicated fatty liver and increased risk for CVD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
Quan, H., Li, B., Couris, C. M., Fushimi, K., Graham, P., Hider, P., Januel, J.-M., & Sundararajan, V. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwq433 · Cited by 5,843
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836
Eslam, M., Newsome, P. N., Sarin, S. K., Anstee, Q. M., Targher, G., Romero-Gomez, M., Zelber-Sagi, S., Wai-Sun Wong, V., Dufour, J.-F., Schattenberg, J. M., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.03.039 · Cited by 4,472
Terrault, N. A., Lok, A. S. F., McMahon, B. J., Chang, K., Hwang, J. P., Jonas, M. M., Brown, R. S., Bzowej, N. H., & Wong, J. B. (2018) · Hepatology · doi:10.1002/hep.29800 · Cited by 4,306
MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease
Eslam, M., Sanyal, A. J., George, J., Sanyal, A., Neuschwander-Tetri, B., Tiribelli, C., Kleiner, D. E., Brunt, E., Bugianesi, E., Yki-Järvinen, H., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.11.312 · Cited by 3,286
Bedogni, G., Bellentani, S., Miglioli, L., Masutti, F., Passalacqua, M., Castiglione, A., & Tiribelli, C. (2006) · BMC Gastroenterology · doi:10.1186/1471-230x-6-33 · Cited by 3,042
Byrne, C. D., & Targher, G. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.12.012 · Cited by 3,042
Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease
Lee, J.-H., Kim, D., Kim, H. J., Lee, C.-H., Yang, J. I., Kim, W., Kim, Y. J., Yoon, J.-H., Cho, S.-H., Sung, M.-W., et al. (2010) · Digestive and Liver Disease · doi:10.1016/j.dld.2009.08.002 · Cited by 1,621
Self-citationNon-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
Targher, G., Byrne, C. D., Lonardo, A., Zoppini, G., & Barbui, C. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.013 · Cited by 1,424
New trends on obesity and NAFLD in Asia
Fan, J.-G., Kim, S.-U., & Wong, V. W.-S. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.06.003 · Cited by 1,083
Self-citationSeong, S. C., Kim, Y.-Y., Park, S. K., Khang, Y. H., Kim, H. C., Park, J. H., Kang, H.-J., Do, C.-H., Song, J.-S., Lee, E.-J., et al. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-016640 · Cited by 830
Self-citationEnvironmental Determinants of Cardiovascular Disease
Bhatnagar, A. (2017) · Circulation Research · doi:10.1161/circresaha.117.306458 · Cited by 603
Comparison of MAFLD and NAFLD diagnostic criteria in real world
Lin, S., Huang, J., Wang, M., Kumar, R., Liu, Y., Liu, S., Wu, Y., Wang, X., & Zhu, Y. (2020) · Liver International · doi:10.1111/liv.14548 · Cited by 516
MAFLD identifies patients with significant hepatic fibrosis better than NAFLD
Yamamura, S., Eslam, M., Kawaguchi, T., Tsutsumi, T., Nakano, D., Yoshinaga, S., Takahashi, H., Anzai, K., George, J., & Torimura, T. (2020) · Liver International · doi:10.1111/liv.14675 · Cited by 401
Lee, Y., Kim, S. U., Song, K., Park, J. Y., Kim, D. Y., Ahn, S. H., Lee, B., Kang, E. S., Cha, B., & Han, K. (2016) · Hepatology · doi:10.1002/hep.28376 · Cited by 340
Self-citationRisk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease
Anstee, Q. M., Mantovani, A., Tilg, H., & Targher, G. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0010-0 · Cited by 310
What are the risk factors and settings for non‐alcoholic fatty liver disease in Asia–Pacific?
Fan, J., Saibara, T., Chitturi, S., Kim, B. I., Sung, J. J. Y., Chutaputti, A., & NAFLD, T. A. W. P. F. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.04952.x · Cited by 267
Lee, H.-Y., Shin, J., Kim, G.-H., Park, S., Ihm, S.-H., Kim, H. C., Kim, K.-I., Kim, J. H., Lee, J. H., Park, J.-M., et al. (2019) · Clinical Hypertension · doi:10.1186/s40885-019-0124-x · Cited by 264
Self-citationPetta, S., Maida, M., Macaluso, F. S., Barbara, M., Licata, A., Craxì, A., & Cammà, C. (2016) · Gastroenterology · doi:10.1053/j.gastro.2015.09.007 · Cited by 254
Baratta, F., Pastori, D., Angelico, F., Balla, A., Paganini, A. M., Cocomello, N., Ferro, D., Violi, F., Sanyal, A. J., & Del Ben, M. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.12.026 · Cited by 248
2018 Guidelines for the management of dyslipidemia
Rhee, E.-J., Kim, H. C., Kim, J. H., Lee, E. Y., Kim, B. J., Kim, E. M., Song, Y., Lim, J. H., Kim, H. J., Choi, S., et al. (2019) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2019.188 · Cited by 213
Self-citationWong, V. W.-S., Wong, G. L.-H., Woo, J., Abrigo, J. M., Chan, C. K.-M., Shu, S. S.-T., Leung, J. K.-Y., Chim, A. M.-L., Kong, A. P.-S., Lui, G. C.-Y., et al. (2021) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.10.046 · Cited by 192
Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis
Adinolfi, L. E., Restivo, L., Zampino, R., Guerrera, B., Lonardo, A., Ruggiero, L., Riello, F., Loria, P., & Florio, A. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.01.051 · Cited by 185
Cardiovascular Risk of Isolated Systolic or Diastolic Hypertension in Young Adults
Lee, H., Yano, Y., Cho, S. M. J., Park, J. H., Park, S., Lloyd-Jones, D. M., & Kim, H. C. (2020) · Circulation · doi:10.1161/circulationaha.119.044838 · Cited by 175
Self-citationLee, Y., Bang, H., Park, Y. M., Bae, J. C., Lee, B., Kang, E. S., Soo, B., Lee, H. C., Balkau, B., Lee, W., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107584 · Cited by 159
Self-citationJung, K. J., Jang, Y., Oh, D. J., Oh, B., Lee, S. H., Park, S., Seung, K. B., Kim, H., Yun, Y. D., Choi, S. H., et al. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.07.033 · Cited by 140
Self-citationLee, Y., Kim, K. J., Yoo, M., Kim, G., Yoon, H.-J., Jo, K., Youn, J., Yun, M., Park, J. Y., Shim, C. Y., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.11.023 · Cited by 139
Self-citationKo, S., Han, K., Lee, Y., Noh, J., Park, C., Kim, D. J., Jung, C. H., Lee, K., & Ko, K. S. (2018) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.42.2.93 · Cited by 117
Self-citationHan, E., Lee, Y., Kim, Y. D., Kim, B. K., Park, J. Y., Kim, D. Y., Ahn, S. H., Lee, B., Kang, E. S., Soo, B., et al. (2020) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000572 · Cited by 115
Self-citationWijarnpreecha, K., Lou, S. M., Panjawatanan, P., Cheungpasitporn, W., Pungpapong, S., Lukens, F., & Ungprasert, P. (2018) · Digestive and Liver Disease · doi:10.1016/j.dld.2018.09.004 · Cited by 82
Metabolic syndrome epidemic among Korean adults: Korean survey of Cardiometabolic Syndrome (2018)
Huh, J. H., Kang, D. R., Jang, J.-Y., Shin, J., Kim, J., Choi, S., Cho, E. J., Park, J., Sohn, I. S., Jo, S., et al. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.08.003 · Cited by 73
Park, J., Kim, B.-G., & Jhun, H. J. (2008) · Journal of Korean Medical Science · doi:10.3346/jkms.2008.23.2.199 · Cited by 50
Liver Fibrosis, Not Steatosis, Associates with Long-Term Outcomes in Ischaemic Stroke Patients
Baik, M., Kim, S. U., Kang, S., Park, H., Nam, H. S., Heo, J. H., Kim, B. K., Park, J. Y., Kim, D. Y., Ahn, S. H., et al. (2019) · Cerebrovascular Diseases · doi:10.1159/000497069 · Cited by 40
Self-citationPatel, S. S., Siddiqui, M. B., Roman, J. H., Zhang, E. D., Lee, E., Shen, S., Faridnia, M., Mintini, R. J., Boyett, S. L., Idowu, M. O., et al. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.09.039 · Cited by 22
Feldman, A., Denkmayr, L., Straßer, M., Ruhaltinger, S., Strebinger, G., Huber-Schönauer, U., Niederseer, D., Stechemesser, L., Zandanell, S., Paulweber, B., et al. (2017) · Journal of Hepatology · doi:10.1016/s0168-8278(17)30570-6 · Cited by 7
Cited by
Epidemiology of metabolic dysfunction-associated steatotic liver disease
Younossi, Z. M., Kalligeros, M., & Henry, L. (2025) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.0431 · Cited by 960
Global Impacts of Western Diet and Its Effects on Metabolism and Health: A Narrative Review
Clemente-Suárez, V. J., Beltrán-Velasco, A. I., Redondo-Flórez, L., Martín-Rodríguez, A., & Tornero-Aguilera, J. F. (2023) · Nutrients · doi:10.3390/nu15122749 · Cited by 804
Mantovani, A., Csermely, A., Petracca, G., Beatrice, G., Corey, K. E., Simon, T. G., Byrne, C. D., & Targher, G. (2021) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(21)00308-3 · Cited by 674
Targher, G., Tilg, H., & Byrne, C. D. (2021) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(21)00020-0 · Cited by 586
MAFLD: How is it different from NAFLD?
Gofton, C., Upendran, Y., Zheng, M.-H., & George, J. (2023) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2022.0367 · Cited by 423
Metadata
- Authors
- Lee, H., Lee, Y.-H., Kim, S. U., & Kim, H. C.
- Venue
- Clinical Gastroenterology and Hepatology
- Publisher
- Elsevier BV
- Published
- 2021-10
- Volume
- 19
- Issue
- 10
- Pages
- 2138-2147.e10
- ISSN
- 1542-3565 (ISSN-L)
- OpenAlex
- W3111217257
- Cited by
- 463
- References
- 37
- FWCI
- 39.47
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.